Releases
-
New therapeutic target for lung cancer
Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. Read MoreNov 12, 2020
-
Breast cancer treatment in older women
A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. Read MoreNov 12, 2020
-
Vanderbilt honors 29 distinguished faculty with endowed chairs
Twenty-nine prominent faculty from across campus comprise Vanderbilt University’s latest endowed chair honorees. They include scholars working in diverse areas—from election analysis and lung cancer research to the nascent field of neurolaw, exploring the brain mechanism underlying legal decision-making. Read MoreNov 11, 2020
-
Ken Wallston, prominent nursing researcher and health psychology pioneer, has died
Kenneth A. Wallston, professor of nursing, emeritus, regarded internationally as one of the founders of health psychology, died in Asheville, North Carolina, on Oct. 27. He was 78. Read MoreNov 11, 2020
-
Ask an Expert: What effect has the pandemic had on the opioid crisis?
Erin Calipari, assistant professor of pharmacology and of psychiatry and behavioral sciences, discusses the COVID-19 pandemic's impact on those struggling with opioid addiction. Read MoreNov 10, 2020
-
Study underscores importance of personalized medicine in kidney cancer
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read MoreNov 10, 2020
-
Vanderbilt and Nashville undertake bold new renewable energy partnership to address climate change
Vanderbilt University and the city of Nashville, Tennessee, have announced a Green Invest partnership with the Tennessee Valley Authority and Nashville Electric Service—a collaboration that will allow the region to take a bold step forward in expanding availability and access to renewable energy at a critical time in global efforts to address the threat of climate change. Read MoreNov 10, 2020
-
Perfecting MRI images with deep learning, Vanderbilt researchers change the way we see the brain
Imaging science experts at Vanderbilt develop deep learning tool to remove distortions in MRI images, decreasing patient time in MRI scanner and correcting legacy images used for teaching. Read MoreNov 10, 2020
-
Vanderbilt environmental engineers appointed to National Academy of Sciences Transportation Research Board executive and climate change adaption committees
Mark Abkowitz and Craig Philip will assume influential positions on the Transportation Research Board, bringing expertise and forward-looking vision to community and infrastructure resiliency planning. Read MoreNov 9, 2020
-
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read MoreNov 9, 2020
-
Madeleine Albright, Colin Powell to headline first Vanderbilt Chancellor’s Lecture Series event for 2020-21
Madeleine K. Albright and Colin L. Powell—the 64th and 65th United States secretaries of state, respectively—will discuss the future of U.S. global relations as part of Vanderbilt University’s first Chancellor’s Lecture Series event of the 2020-21 season. Read MoreNov 9, 2020
-
University to salute character and resilience of Vanderbilt veterans
Vanderbilt University is honoring the service of military veterans and celebrating their unique contributions to campus culture through a series of videos, social media posts, photo exhibitions and more to commemorate Veterans Day. Watch a video message from Chancellor Daniel Diermeier saluting Vanderbilt's veterans. Read MoreNov 9, 2020
-
Vanderbilt biologist uses rabies-like virus to illuminate how SARS-CoV-2 blocks immune response
Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics. Read MoreNov 9, 2020
-
Paul Jacobson, EVP and CFO of Delta Air Lines, discusses impact of pandemic on aviation at Owen Forward
Delta Air Lines' Paul Jacobson will discuss the impact of the COVID-19 pandemic on aviation as part of Owen Forward. Jacobson will be joined by M. Eric Johnson, Owen dean and Bruce D. Henderson Professor of Strategy, for the talk on Wednesday, Nov. 11. Read MoreNov 6, 2020
-
Honey bees lose sleep after ingesting pesticides, leading to greater stress and lower hive survival rates
Vanderbilt research shows the unintended consequence of pesticides is the death of a bee’s circadian rhythm, not the bee herself. Read MoreNov 5, 2020
-
New research documents how COVID-19 multiplies stress and trauma for people with disabilities
A November article published in Rehabilitation Psychology reviews research on disabilities and COVID-19 to help rehabilitation psychologists mitigate the effects of the added stress of the pandemic. In addition, the work addresses how systemic discrimination against people with disabilities intersects with other forms of inequity. Read MoreNov 4, 2020
-
Nancy Carrasco’s pioneering public health work recognized with National Academy of Medicine election
Nancy Carrasco, professor and chair of the Department of Molecular Physiology and Biophysics and the Joe C. Davis Chair of Biomedical Science, receives one of the highest honors in health and medicine. Read MoreNov 4, 2020
-
Velma McBride Murry’s pathbreaking family intervention work recognized with National Academy of Medicine election
Velma McBride Murry, University Professor of Health Policy and Human & Organizational Development, receives one of the highest honors in health and medicine. Read MoreNov 4, 2020
-
Spontaneous release of neurotransmitters in the brain identified as a culprit of developmental disorders in infants and children
Vanderbilt researchers discover how a group of neurodevelopmental disorders ranging in severity are caused in infants and children, opening new avenues for therapeutics. Read MoreNov 3, 2020
-
New treatment for a rare obesity
Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity. Read MoreNov 3, 2020